In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

Researchers engineered a bespoke CRISPR-Cas9 gene-editing enzyme to develop a potential therapy for MSMDS, which ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

The collaboration provides VedaBio access to essential CRISPR IP, accelerating the development of customised diagnostic ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Researchers developed TESLA-seq, a CRISPR-based method to map DNA regions that regulate genes. By scanning thousands of ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

Scientists at the University of California, Davis, have developed wheat plants that stimulate production of its own fertilizer, which could bring environmental and cost-reduction benefits. A study was ...